Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 2Phase 1 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Paclitaxel-induced Neuropathy 1Esophageal Neoplasms 1

Interventions

Paclitaxel 292Gemcitabine 254Carboplatin 254Cisplatin 251Radiotherapy 219Cyclophosphamide 218Irinotecan 184pembrolizumab 181Docetaxel 174Bevacizumab 166Capecitabine 148Nivolumab 141Fluorouracil 132Dexamethasone 125Bortezomib 123Oxaliplatin 115Cytarabine 113Erlotinib Hydrochloride 112Temozolomide 110Sorafenib 110Doxorubicin 106Rituximab 105Leucovorin 105Etoposide 105Filgrastim 99Everolimus 97Lenalidomide 95Pemetrexed 90Ipilimumab 90fludarabine phosphate 84

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Completed × Calcium Gluconate × Clear all
NCT04958044 2022-10-26

Endoscopic Assisted Calcium Electroporation in Esophageal Cancer

Rigshospitalet, Denmark

Phase 1 Completed
10 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT01682499 2014-09-25

Calcium and Magnesium Infusion for the Prevention of Taxane Induced Neuropathy

Beth Israel Medical Center

Phase 1 Completed
50 enrolled

Paclitaxel-induced Neuropathy

Data powered by HemOnc (CC BY 4.0) Colophon âš¡